GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PCI Biotech Holding ASA (LTS:0JGL) » Definitions » Pre-Tax Income

PCI Biotech Holding ASA (LTS:0JGL) Pre-Tax Income : kr-29.11 Mil (TTM As of Jun. 2023)


View and export this data going back to 2008. Start your Free Trial

What is PCI Biotech Holding ASA Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. PCI Biotech Holding ASA's pretax income for the three months ended in Jun. 2023 was kr-5.76 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2023 was kr-29.11 Mil. PCI Biotech Holding ASA's pretax margin was %.


PCI Biotech Holding ASA Pre-Tax Income Historical Data

The historical data trend for PCI Biotech Holding ASA's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCI Biotech Holding ASA Pre-Tax Income Chart

PCI Biotech Holding ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -88.75 -72.24 -88.39 -55.10 -20.32

PCI Biotech Holding ASA Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.70 -6.70 -5.96 -5.76 -

Competitive Comparison of PCI Biotech Holding ASA's Pre-Tax Income

For the Biotechnology subindustry, PCI Biotech Holding ASA's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PCI Biotech Holding ASA's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PCI Biotech Holding ASA's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where PCI Biotech Holding ASA's Pre-Tax Income falls into.



PCI Biotech Holding ASA Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

PCI Biotech Holding ASA's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-22.241+0+-0.159+2.086+-0.0010000000000012
=-20.32

PCI Biotech Holding ASA's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-6.325+0+-0.044+0.567+0.042999999999999
=-5.76

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-29.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PCI Biotech Holding ASA  (LTS:0JGL) Pre-Tax Income Explanation

PCI Biotech Holding ASA's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-5.759/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PCI Biotech Holding ASA Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of PCI Biotech Holding ASA's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


PCI Biotech Holding ASA (LTS:0JGL) Business Description

Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, N-0379
PCI Biotech Holding ASA is a biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The PCI technology works by inducing light-triggered endosomal release. PCI is applied to three distinct anticancer paradigms; fimaCHEM which is an enhancement of chemotherapeutics for localized treatment of cancer, fimaVACC which is T-cell induction technology for therapeutic vaccination, and fimaNAc which is nucleic acid therapeutics delivery. Its therapeutic product candidate is the photosensitizer fimaporfin (Amphinex) which can unlock the intracellular capsules where active compounds are trapped.

PCI Biotech Holding ASA (LTS:0JGL) Headlines

No Headlines